FDA 483 - BEO Pharma Inc - November 04, 2024
FDA 483 for BEO Pharma Inc on November 04, 2024. Product: drugs. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for BEO Pharma Inc on November 04, 2024. Product: drugs. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
BEO Pharma IncInspection Date
November 4, 2024
Product Type
drugs
Office
Florida District OfficeID: 48de809c-ed40-458c-a612-ec39ca58b26a
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox